Literature DB >> 11287677

Design of inhibitors of Ras--Raf interaction using a computational combinatorial algorithm.

J Zeng1, T Nheu, A Zorzet, B Catimel, E Nice, H Maruta, A W Burgess, H R Treutlein.   

Abstract

Drugs that inhibit important protein-protein interactions are hard to find either by screening or rational design, at least so far. Most drugs on the market that target proteins today are therefore aimed at well-defined binding pockets in proteins. While computer-aided design is widely used to facilitate the drug discovery process for binding pockets, its application to the design of inhibitors that target the protein surface initially seems to be limited because of the increased complexity of the task. Previously, we had started to develop a computational combinatorial design approach based on the well-known 'multiple copy simultaneous search' (MCSS) procedure to tackle this problem. In order to identify sequence patterns of potential inhibitor peptides, a three-step procedure is employed: first, using MCSS, the locations of specific functional groups on the protein surface are identified; second, after constructing the peptide main chain based on the location of favorite locations of N-methylacetamide groups, functional groups corresponding to amino acid side chains are selected and connected to the main chain C(alpha) atoms; finally, the peptides generated in the second step are aligned and probabilities of amino acids at each position are calculated from the alignment scheme. Sequence patterns of potential inhibitors are determined based on the propensities of amino acids at each C(alpha) position. Here we report the optimization of inhibitor peptides using the sequence patterns determined by our method. Several short peptides derived from our prediction inhibit the Ras--Raf association in vitro in ELISA competition assays, radioassays and biosensor-based assays, demonstrating the feasibility of our approach. Consequently, our method provides an important step towards the development of novel anti-Ras agents and the structure-based design of inhibitors of protein--protein interactions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287677     DOI: 10.1093/protein/14.1.39

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  11 in total

Review 1.  From laptop to benchtop to bedside: structure-based drug design on protein targets.

Authors:  Lu Chen; John K Morrow; Hoang T Tran; Sharangdhar S Phatak; Lei Du-Cuny; Shuxing Zhang
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 2.  The multi-copy simultaneous search methodology: a fundamental tool for structure-based drug design.

Authors:  Christian R Schubert; Collin M Stultz
Journal:  J Comput Aided Mol Des       Date:  2009-06-09       Impact factor: 3.686

3.  Computational identification of epitopes in the glycoproteins of novel bunyavirus (SFTS virus) recognized by a human monoclonal antibody (MAb 4-5).

Authors:  Wenshuai Zhang; Xiaoyan Zeng; Li Zhang; Haiyan Peng; Yongjun Jiao; Jun Zeng; Herbert R Treutlein
Journal:  J Comput Aided Mol Des       Date:  2013-07-10       Impact factor: 3.686

4.  Total Chemical Synthesis and Folding of All-l and All-d Variants of Oncogenic KRas(G12V).

Authors:  Adam M Levinson; John H McGee; Andrew G Roberts; Gardner S Creech; Ting Wang; Michael T Peterson; Ronald C Hendrickson; Gregory L Verdine; Samuel J Danishefsky
Journal:  J Am Chem Soc       Date:  2017-05-22       Impact factor: 15.419

5.  Neuronal nitric oxide synthase-induced S-nitrosylation of H-Ras inhibits calcium ionophore-mediated extracellular-signal-regulated kinase activity.

Authors:  Kimberly W Raines; Guan-Liang Cao; Eun Kyoung Lee; Gerald M Rosen; Paul Shapiro
Journal:  Biochem J       Date:  2006-07-15       Impact factor: 3.857

6.  Characterization of ATP-independent ERK inhibitors identified through in silico analysis of the active ERK2 structure.

Authors:  Fengming Chen; Chad N Hancock; Alba T Macias; Joseph Joh; Kimberly Still; Shijun Zhong; Alexander D MacKerell; Paul Shapiro
Journal:  Bioorg Med Chem Lett       Date:  2006-09-26       Impact factor: 2.823

7.  Computer applications for prediction of protein-protein interactions and rational drug design.

Authors:  Solène Grosdidier; Max Totrov; Juan Fernández-Recio
Journal:  Adv Appl Bioinform Chem       Date:  2009-11-10

8.  Inhibition of the Ras/Raf interaction and repression of renal cancer xenografts in vivo by an enantiomeric iridium(iii) metal-based compound.

Authors:  Li-Juan Liu; Wanhe Wang; Shi-Ying Huang; Yanjun Hong; Guodong Li; Sheng Lin; Jinglin Tian; Zongwei Cai; Hui-Min David Wang; Dik-Lung Ma; Chung-Hang Leung
Journal:  Chem Sci       Date:  2017-05-16       Impact factor: 9.825

9.  In Silico Generation of Peptides by Replica Exchange Monte Carlo: Docking-Based Optimization of Maltose-Binding-Protein Ligands.

Authors:  Anna Russo; Pasqualina Liana Scognamiglio; Rolando Pablo Hong Enriquez; Carlo Santambrogio; Rita Grandori; Daniela Marasco; Antonio Giordano; Giacinto Scoles; Sara Fortuna
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

10.  Antibody recognition of Shiga toxins (Stxs): computational identification of the epitopes of Stx2 subunit A to the antibodies 11E10 and S2C4.

Authors:  Yongjun Jiao; Fiona S Legge; Xiaoyan Zeng; Herbert R Treutlein; Jun Zeng
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.